These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 37762422)

  • 41. Biochemical and structural analysis of missense mutations in N-acetylgalactosamine-6-sulfate sulfatase causing mucopolysaccharidosis IVA phenotypes.
    Sukegawa K; Nakamura H; Kato Z; Tomatsu S; Montaño AM; Fukao T; Toietta G; Tortora P; Orii T; Kondo N
    Hum Mol Genet; 2000 May; 9(9):1283-90. PubMed ID: 10814710
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of disease-specific chondroitin sulfate nonreducing end accumulation in mucopolysaccharidosis IVA.
    Lawrence R; Prill H; Vachali PP; Adintori EG; de Hart G; Wang RY; Burton BK; Pasquali M; Crawford BE
    Glycobiology; 2020 Jul; 30(7):433-445. PubMed ID: 31897472
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mucopolysaccharidosis type IV: N-acetylgalactosamine-6-sulfatase mutations in Tunisian patients.
    Laradi S; Tukel T; Khediri S; Shabbeer J; Erazo M; Chkioua L; Chaabouni M; Ferchichi S; Miled A; Desnick RJ
    Mol Genet Metab; 2006 Mar; 87(3):213-8. PubMed ID: 16378744
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mucopolysaccharidosis IVA: identification of a common missense mutation I113F in the N-Acetylgalactosamine-6-sulfate sulfatase gene.
    Tomatsu S; Fukuda S; Cooper A; Wraith JE; Rezvi GM; Yamagishi A; Yamada N; Kato Z; Isogai K; Sukegawa K
    Am J Hum Genet; 1995 Sep; 57(3):556-63. PubMed ID: 7668283
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of genes involved in apoptosis is dysregulated in mucopolysaccharidoses as revealed by pilot transcriptomic analyses.
    Brokowska J; Pierzynowska K; Gaffke L; Rintz E; Węgrzyn G
    Cell Biol Int; 2021 Mar; 45(3):549-557. PubMed ID: 32125037
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A pictorial review of the radiographic skeletal findings in Morquio syndrome (mucopolysaccharidosis type IV).
    Padash S; Obaid H; Henderson RDE; Padash Y; Adams SJ; Miller SF; Babyn P
    Pediatr Radiol; 2023 May; 53(5):971-983. PubMed ID: 36627376
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Murine model (Galns(tm(C76S)slu)) of MPS IVA with missense mutation at the active site cysteine conserved among sulfatase proteins.
    Tomatsu S; Vogler C; Montaño AM; Gutierrez M; Oikawa H; Dung VC; Orii T; Noguchi A; Sly WS
    Mol Genet Metab; 2007 Jul; 91(3):251-8. PubMed ID: 17498992
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [GLB1 gene mutation and clinical characteristics of a patient with mucopolysaccharidosis type IVB].
    Lei HL; Ye J; Qiu WJ; Zhang HW; Han LS; Gu XF
    Zhonghua Er Ke Za Zhi; 2012 Jul; 50(7):549-53. PubMed ID: 22932019
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mucopolysaccharidosis IVA and glycosaminoglycans.
    Khan S; Alméciga-Díaz CJ; Sawamoto K; Mackenzie WG; Theroux MC; Pizarro C; Mason RW; Orii T; Tomatsu S
    Mol Genet Metab; 2017; 120(1-2):78-95. PubMed ID: 27979613
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impaired degradation of keratan sulphate by Morquio A fibroblasts.
    Glössl J; Kresse H
    Biochem J; 1982 Apr; 203(1):335-8. PubMed ID: 6213226
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular basis of mucopolysaccharidosis IVA (Morquio A syndrome): A review and classification of GALNS gene variants and reporting of 68 novel variants.
    Zanetti A; D'Avanzo F; AlSayed M; Brusius-Facchin AC; Chien YH; Giugliani R; Izzo E; Kasper DC; Lin HY; Lin SP; Pollard L; Singh A; Tonin R; Wood T; Morrone A; Tomanin R
    Hum Mutat; 2021 Nov; 42(11):1384-1398. PubMed ID: 34387910
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The structure of human GALNS reveals the molecular basis for mucopolysaccharidosis IV A.
    Rivera-Colón Y; Schutsky EK; Kita AZ; Garman SC
    J Mol Biol; 2012 Nov; 423(5):736-51. PubMed ID: 22940367
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel data on growth phenotype and causative genotypes in 29 patients with Morquio (Morquio-Brailsford) syndrome from Central-Eastern Europe.
    Jezela-Stanek A; Różdżyńska-Świątkowska A; Kulpanovich A; Ciara E; Marucha J; Tylki-Szymańska A
    J Appl Genet; 2019 May; 60(2):163-174. PubMed ID: 30927141
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Morquio A syndrome-associated mutations: a review of alterations in the GALNS gene and a new locus-specific database.
    Morrone A; Caciotti A; Atwood R; Davidson K; Du C; Francis-Lyon P; Harmatz P; Mealiffe M; Mooney S; Oron TR; Ryles A; Zawadzki KA; Miller N
    Hum Mutat; 2014 Nov; 35(11):1271-9. PubMed ID: 25137622
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Polymorphisms in Tunisian patients with N-acetylgalactosamine-6-sulfate sulfatase gene deficiency: implication in Morquio A disease.
    Khedhiri S; Chkioua L; Ferchichi S; Miled A; Laradi S
    Diagn Pathol; 2011 Jan; 6():11. PubMed ID: 21251309
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oxidative profile exhibited by Mucopolysaccharidosis type IVA patients at diagnosis: Increased keratan urinary levels.
    Donida B; Marchetti DP; Jacques CED; Ribas G; Deon M; Manini P; da Rosa HT; Moura DJ; Saffi J; Giugliani R; Vargas CR
    Mol Genet Metab Rep; 2017 Jun; 11():46-53. PubMed ID: 28487826
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development of MPS IVA mouse (Galnstm(hC79S.mC76S)slu) tolerant to human N-acetylgalactosamine-6-sulfate sulfatase.
    Tomatsu S; Gutierrez M; Nishioka T; Yamada M; Yamada M; Tosaka Y; Grubb JH; Montaño AM; Vieira MB; Trandafirescu GG; Peña OM; Yamaguchi S; Orii KO; Orii T; Noguchi A; Laybauer L
    Hum Mol Genet; 2005 Nov; 14(22):3321-35. PubMed ID: 16219627
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical, biochemical and molecular findings in a two-generation Morquio A family.
    Tylki-Szymańska A; Czartoryska B; Bunge S; van Diggelen OP; Kleijer WJ; Poorthuis BJ; Huijmans JG; Górska D
    Clin Genet; 1998 May; 53(5):369-74. PubMed ID: 9660054
    [TBL] [Abstract][Full Text] [Related]  

  • 59. N-acetylgalactosamine-6-sulfatase protein detection in MPS IVA patient and unaffected control samples.
    Parkinson-Lawrence EJ; Muller VJ; Hopwood JJ; Brooks DA
    Clin Chim Acta; 2007 Feb; 377(1-2):88-91. PubMed ID: 17027703
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Spondyloepiphyseal dysplasias and bilateral legg-calvé-perthes disease: diagnostic considerations for mucopolysaccharidoses.
    Mendelsohn NJ; Wood T; Olson RA; Temme R; Hale S; Zhang H; Read L; White KK
    JIMD Rep; 2013; 11():125-32. PubMed ID: 23657977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.